A Secret Weapon For M3541
The primary finish stage was the safety and tolerability of sifalimumab. Therapy-emergent adverse occasions (AEs) and serious AEs (SAEs) as well as their severity, outcome, and any relationship to your research medication have been recorded from the investigator all over the research. AEs were being considered more likely to be linked to analyze me